| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Molecular Hepatology Laboratory, Massachusetts General Hospital Cancer Center, Departments of Medicine and Pathology, Harvard Medical School, Charlestown, Massachusetts 02129
The human aspartyl (asparaginyl) ß-hydroxylase (HAAH) is a highly conserved enzyme that hydroxylates epidermal growth factor-like domains in transformation-associated proteins. We previously reported overexpression of the HAAH gene in human hepatocellular carcinomas and cholangiocarcinomas (L. Lavaissiere et al., J. Clin. Investig., 98: 13131323, 1996). In the present study, we determined whether HAAH protein overexpression was linked to cellular proliferation or malignant transformation of bile ducts by using a human disease and rat model of bile duct proliferation. In addition, the transforming properties of the AAH genes were assessed by transient and stable transfection of NIH-3T3 cells with human and murine wild-type as well as mutant cDNA constructs that lacked hydroxylation activity. Cellular characteristics of the malignant phenotype were assessed by formation of transformed foci, growth in soft agar, and tumor development in nude mice. We found that HAAH gene expression was undetectable during bile duct proliferation in both human disease and rat models as compared with cholangiocarcinoma. Overexpression of HAAH in NIH-3T3 cells was associated with generation of a malignant phenotype, and enzymatic activity was required for cellular transformation. These findings suggest that overexpression of HAAH is linked to cellular transformation of biliary epithelial cells.
This article has been cited by other articles:
![]() |
S. P. Ho, M. S. Scully, C. M. Krauthauser, E. J. Wexler, M. D. Stow, J. E. Dinchuk, J. S. Kerr, and P. A. Friedman Antisense Oligonucleotides Selectively Regulate Aspartyl beta -Hydroxylase and Its Truncated Protein Isoform in Vitro but Distribute Poorly into A549 Tumors in Vivo J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 795 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Kaelin Jr. How oxygen makes its presence felt Genes & Dev., June 15, 2002; 16(12): 1441 - 1445. [Full Text] [PDF] |
||||
![]() |
J. E. Dinchuk, R. J. Focht, J. A. Kelley, N. L. Henderson, N. I. Zolotarjova, R. Wynn, N. T. Neff, J. Link, R. M. Huber, T. C. Burn, et al. Absence of Post-translational Aspartyl beta -Hydroxylation of Epidermal Growth Factor Domains in Mice Leads to Developmental Defects and an Increased Incidence of Intestinal Neoplasia J. Biol. Chem., April 5, 2002; 277(15): 12970 - 12977. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Dinchuk, N. L. Henderson, T. C. Burn, R. Huber, S. P. Ho, J. Link, K. T O'Neil, R. J. Focht, M. S. Scully, J. M. Hollis, et al. Aspartyl beta -Hydroxylase (Asph) and an Evolutionarily Conserved Isoform of Asph Missing the Catalytic Domain Share Exons with Junctin J. Biol. Chem., December 8, 2000; 275(50): 39543 - 39554. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |